Europe extends BST ban
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.European ministers have voted to extend the ban on the controversial milk-boosting drug for cattle, bovine somatotropin (BST), until the year 2000.
The genetically engineered drug is a flagship product of the struggling biotechnology industry. It is produced by several companies, including Monsanto and Eli Lilly, who between them have invested millions of pounds in its development.
BST was approved for commerical use in the US last year, where reaction from consumers, farmers and retailers to use of the drug has been cool.
On Thursday, the Council of Ministers said it wanted BST manufacturers to collect more "scientific data" on its effect on treated cows. Britain and Denmark voted against the ban. This is despite a ruling last year by the Committee for Veterinary and Medicinal Products that there were no animal or human health grounds on which it would prevent the drug's use.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments